Bryan R. Becklund

845 total citations
11 papers, 693 citations indexed

About

Bryan R. Becklund is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Bryan R. Becklund has authored 11 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Bryan R. Becklund's work include Vitamin D Research Studies (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and CAR-T cell therapy research (2 papers). Bryan R. Becklund is often cited by papers focused on Vitamin D Research Studies (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and CAR-T cell therapy research (2 papers). Bryan R. Becklund collaborates with scholars based in United States, South Korea and Switzerland. Bryan R. Becklund's co-authors include Hector F. DeLuca, Marissa I. Boulware, P. Mermelstein, Rachel D. Groth, Sidney P. Kuo, Jason P. Weick, Kyle S. Severson, Yongji Wang, Gor Sarkisyan and Tobias K. Vogt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Bryan R. Becklund

11 papers receiving 683 citations

Peers

Bryan R. Becklund
Elizabeth Umeda United States
Ronald L. Wilder United States
William J. DeVito United States
Elizabeth Umeda United States
Bryan R. Becklund
Citations per year, relative to Bryan R. Becklund Bryan R. Becklund (= 1×) peers Elizabeth Umeda

Countries citing papers authored by Bryan R. Becklund

Since Specialization
Citations

This map shows the geographic impact of Bryan R. Becklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan R. Becklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan R. Becklund more than expected).

Fields of papers citing papers by Bryan R. Becklund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan R. Becklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan R. Becklund. The network helps show where Bryan R. Becklund may publish in the future.

Co-authorship network of co-authors of Bryan R. Becklund

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan R. Becklund. A scholar is included among the top collaborators of Bryan R. Becklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan R. Becklund. Bryan R. Becklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kasiewicz, Melissa J., Annah S. Rolig, Bryan R. Becklund, et al.. (2025). INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering. Journal for ImmunoTherapy of Cancer. 13(5). e011524–e011524. 4 indexed citations
2.
Kalabus, James, Bryan R. Becklund, Florian J. Sulzmaier, et al.. (2021). 12 Key pharmacokinetic and pharmacodynamic parameters that correlate with the anti-tumor activity of a bispecific PD-L1 conditional 4–1BB agonist. SHILAP Revista de lepidopterología. A12–A12. 1 indexed citations
3.
Rowell, Emily, Bryan R. Becklund, Florian J. Sulzmaier, et al.. (2021). 856 INBRX-106: a novel hexavalent anti-OX40 agonist for the treatment of solid tumors. SHILAP Revista de lepidopterología. A897–A897. 8 indexed citations
4.
Becklund, Bryan R., et al.. (2018). Self-Recognition Sensitizes Mouse and Human Regulatory T Cells to Low-Dose CD28 Superagonist Stimulation. Frontiers in Immunology. 8. 1985–1985. 7 indexed citations
5.
Becklund, Bryan R., Jared F. Purton, Chris Ramsey, et al.. (2016). The aged lymphoid tissue environment fails to support naïve T cell homeostasis. Scientific Reports. 6(1). 30842–30842. 91 indexed citations
6.
Becklund, Bryan R., et al.. (2010). UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proceedings of the National Academy of Sciences. 107(14). 6418–6423. 160 indexed citations
7.
Becklund, Bryan R., et al.. (2010). Reply to Handunnetthi and Ramagopalan: UV radiation, experimental autoimmune encephalomyelitis, and multiple sclerosis. Proceedings of the National Academy of Sciences. 107(33). 1 indexed citations
8.
Wang, Yongji, Bryan R. Becklund, & Hector F. DeLuca. (2009). Identification of a highly specific and versatile vitamin D receptor antibody. Archives of Biochemistry and Biophysics. 494(2). 166–177. 66 indexed citations
9.
Becklund, Bryan R., et al.. (2009). The calcitonin/calcitonin gene related peptide-α gene is not required for 1α,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis. Archives of Biochemistry and Biophysics. 488(2). 105–108. 3 indexed citations
10.
Becklund, Bryan R., et al.. (2009). Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin. Proceedings of the National Academy of Sciences. 106(13). 5276–5281. 25 indexed citations
11.
Boulware, Marissa I., Jason P. Weick, Bryan R. Becklund, et al.. (2005). Estradiol Activates Group I and II Metabotropic Glutamate Receptor Signaling, Leading to Opposing Influences on cAMP Response Element-Binding Protein. Journal of Neuroscience. 25(20). 5066–5078. 327 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026